Primer on Tumor Immunology and Biological Therapy
of Cancer
October 30, 2008
Westin Gaslamp Quarter Hotel
San Diego, CA
This primer will provide a current overview of immunology as it applies to cancer etiology, biology and therapy. The target audience for this program is basic and clinical investigators from academic, regulatory, and biopharmaceutical venues. The audience includes clinicians, researchers, students, post-doctoral fellows, and allied health professionals.
| Topics to be Addressed |
- Adoptive T Cell Therapy
- Anti-Angiogenic Therapies
- Antibody Therapy of Cancer
- Approach to Identifying and Therapeutic Exploitation of Tumor Antigens
- Blocking Anti-T Cell Checkpoints
|
- Cytokines
- Immune Adjuvants
- Immune Monitoring
- Mechanisms of Immune-Mediated Tumor Lysis
- T Reg Cells
|
Program Objectives
- Provide a current overview of immunology as it applies to cancer etiology, biology and therapy
- Present in-depth concepts of cellular immunology and the host-tumor-immune system interactions
- Present in-depth concepts of humorally-based immune therapies
- Present in-depth concepts of cytokine biology and its role in cancer therapy
- Educate the audience regarding the foundation and methods for clinical trials of biologic/immunologic therapies
Expected Outcomes
Attendees will learn the current status and the most recent advances in biologic therapies including cancer vaccines, vaccine adjuvants, host-tumor interactions and the role of the innate and adaptive immune systems in tumor immunology and therapy.
| Organizers |
Kim Margolin, MD
City of Hope Cancer Center |
Patrick Hwu, MD
MD Anderson Cancer Center |
